Fuller Ashley M, Eisinger-Mathason Tzipora S Karin
Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cancers (Basel). 2022 Jun 26;14(13):3132. doi: 10.3390/cancers14133132.
The deposition of collagen-rich desmoplastic tissue is a well-documented feature of the solid tumor microenvironment (TME). However, efforts to target the desmoplastic extracellular matrix (ECM) en masse, or collagen molecules more specifically, have been met with mixed and sometimes paradoxical results. In this review, we posit that these discrepancies are due-at least in part-to the incredible diversity of the collagen superfamily. Specifically, whereas studies of "collagen-targeting" approaches frequently refer to "collagen" as a single molecule or relatively homogeneous molecular family, 28 individual collagens have been identified in mammalian tissues, each with a unique structure, supramolecular assembly pattern, tissue distribution, and/or function. Moreover, some collagen species have been shown to exert both pro- and anti-neoplastic effects in the desmoplastic TME, even within the same cancer type. Therefore, herein, we describe the diversity of the collagen family in normal tissues and highlight the context-specific roles of individual collagen molecules in desmoplastic tumors. We further discuss how this heterogeneity relates to the variable efficacy of "collagen-targeting" strategies in this setting and provide guidance for future directions in the field.
富含胶原蛋白的促纤维增生性组织的沉积是实体瘤微环境(TME)的一个有充分文献记载的特征。然而,针对促纤维增生性细胞外基质(ECM)整体,或者更具体地针对胶原蛋白分子的研究,结果却喜忧参半,有时甚至自相矛盾。在本综述中,我们认为这些差异至少部分归因于胶原蛋白超家族令人难以置信的多样性。具体而言,虽然“靶向胶原蛋白”方法的研究经常将“胶原蛋白”视为单一分子或相对同质的分子家族,但在哺乳动物组织中已鉴定出28种不同的胶原蛋白,每种都具有独特的结构、超分子组装模式、组织分布和/或功能。此外,一些胶原蛋白种类已被证明在促纤维增生性TME中甚至在同一癌症类型中都发挥着促肿瘤和抗肿瘤的双重作用。因此,在本文中,我们描述了正常组织中胶原蛋白家族的多样性,并强调了单个胶原蛋白分子在促纤维增生性肿瘤中的特定背景作用。我们还进一步讨论了这种异质性如何与该环境中“靶向胶原蛋白”策略的可变疗效相关,并为该领域的未来方向提供指导。